Fig. 5From: Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world studyWANECAM (SP-C-013-11): PCR-adjusted ACPR by body weight (PP population). A Day 28 PCR-adjusted ACPR. B Day 42 PCR-adjusted ACPR. ACPR adequate clinical and parasitological response, AL artemether–lumefantrine, ASAQ artesunate–amodiaquine, PA pyronaridine–artesunate, PCR polymerase chain reaction, PP per-protocolBack to article page